Journal Watch
-
Daily HD survival compares to transplant
A study by Kjellstrand et. al. pooling data from 1006 short daily HD patient years (415 patients, both at home and in-center) found 2–3 times better survival than on standard in-center HD. In fact, survival with daily HD was similar to that of deceased donor transplant. (Interesting that no-one disputes that survival is better with transplant than standard HD—though patients are selected for it (just as for home HD) and no randomized controlled trial has been done.)
Read the abstract » | (added 2011-02-24)
Tags:
-
New study: Survival benefit for nocturnal HD
Researchers from the U.S. and Canada matched each of 94 people on nocturnal HD and 43 on short daily HD to 10 controls on standard HD. Even using the "proportional hazards model", they found a significantly lower risk of hospitalization and death on nocturnal, and a lower (but not significant) risk for daily, too.
Read the abstract » | (added 2011-02-24)
Tags:
-
Secondary arteriovenous fistulas: Converting prosthetic AV grafts to autogenous dialysis access
Dialysis fistulas tend to have fewer clots, infections, and hospital stays than grafts. Switching from a graft to a fistula was highly (90%+) successful after 2 years in a new study.
Read the abstract » | (added 2011-02-24)
Tags: